Should we use intensive hypoglycemic treatment in patients with advanced type 2 diabetes?

Pol Arch Med Wewn. 2014;124(12):657-8. doi: 10.20452/pamw.2544. Epub 2014 Nov 14.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Diabetes Mellitus, Type 2 / drug therapy*
  • Glycated Hemoglobin / analysis
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Treatment Outcome

Substances

  • Glycated Hemoglobin A
  • Hypoglycemic Agents